nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.51	0.586	CbGaD
Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.36	0.413	CbGaD
Acetophenazine—DRD1—Dopamine receptors—DRD5—attention deficit hyperactivity disorder	0.0103	0.087	CbGpPWpGaD
Acetophenazine—DRD2—Dopamine receptors—DRD5—attention deficit hyperactivity disorder	0.0078	0.0657	CbGpPWpGaD
Acetophenazine—DRD1—Dopamine receptors—DRD3—attention deficit hyperactivity disorder	0.00563	0.0475	CbGpPWpGaD
Acetophenazine—DRD1—Dopamine receptors—DRD4—attention deficit hyperactivity disorder	0.00547	0.0461	CbGpPWpGaD
Acetophenazine—DRD1—Dopamine receptors—DRD2—attention deficit hyperactivity disorder	0.00509	0.0429	CbGpPWpGaD
Acetophenazine—DRD2—Dopamine receptors—DRD1—attention deficit hyperactivity disorder	0.00439	0.037	CbGpPWpGaD
Acetophenazine—DRD2—Dopamine receptors—DRD3—attention deficit hyperactivity disorder	0.00425	0.0358	CbGpPWpGaD
Acetophenazine—DRD2—Dopamine receptors—DRD4—attention deficit hyperactivity disorder	0.00413	0.0348	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00233	0.0196	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00228	0.0192	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00196	0.0165	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00192	0.0162	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00176	0.0148	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00172	0.0145	CbGpPWpGaD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—attention deficit hyperactivity disorder	0.0015	0.0126	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00148	0.0125	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00145	0.0122	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00138	0.0117	CbGpPWpGaD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—attention deficit hyperactivity disorder	0.00135	0.0114	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00133	0.0112	CbGpPWpGaD
Acetophenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.00131	0.011	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00124	0.0105	CbGpPWpGaD
Acetophenazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.00124	0.0104	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00122	0.0103	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00121	0.0102	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00116	0.0098	CbGpPWpGaD
Acetophenazine—DRD1—Hypothetical Network for Drug Addiction—DRD2—attention deficit hyperactivity disorder	0.00115	0.00973	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00113	0.00949	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00105	0.00882	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00104	0.0088	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00867	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00102	0.00856	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.001	0.00846	CbGpPWpGaD
Acetophenazine—DRD2—Hypothetical Network for Drug Addiction—DRD1—attention deficit hyperactivity disorder	0.000995	0.00838	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00097	0.00818	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000946	0.00798	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00094	0.00792	CbGpPWpGaD
Acetophenazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—attention deficit hyperactivity disorder	0.000935	0.00788	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000924	0.00779	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000912	0.00769	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000877	0.0074	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000816	0.00688	CbGpPWpGaD
Acetophenazine—DRD1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.000791	0.00667	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00079	0.00666	CbGpPWpGaD
Acetophenazine—DRD1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000788	0.00665	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000777	0.00655	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000767	0.00646	CbGpPWpGaD
Acetophenazine—DRD1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000663	0.00559	CbGpPWpGaD
Acetophenazine—DRD2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000595	0.00502	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.000545	0.0046	CbGpPWpGaD
Acetophenazine—DRD2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0005	0.00422	CbGpPWpGaD
Acetophenazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.000464	0.189	CbGeAlD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000449	0.00379	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00044	0.00371	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000437	0.00369	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000385	0.00325	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000379	0.00319	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000377	0.00318	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.000366	0.00308	CbGpPWpGaD
Acetophenazine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000343	0.0383	CrCbGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000339	0.00286	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000332	0.0028	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00033	0.00278	CbGpPWpGaD
Acetophenazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.000306	0.125	CbGeAlD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000305	0.00257	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000303	0.00255	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000293	0.00247	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000293	0.00247	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000291	0.00245	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000287	0.00242	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000286	0.00241	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000285	0.0024	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000285	0.0024	CbGpPWpGaD
Acetophenazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000274	0.111	CbGeAlD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000267	0.00225	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000265	0.00224	CbGpPWpGaD
Acetophenazine—Flupentixol—DRD1—attention deficit hyperactivity disorder	0.000264	0.0295	CrCbGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000262	0.0022	CbGpPWpGaD
Acetophenazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000252	0.102	CbGeAlD
Acetophenazine—DRD2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000248	0.00209	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000247	0.00208	CbGpPWpGaD
Acetophenazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000243	0.0986	CbGeAlD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00024	0.00202	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000236	0.00199	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000233	0.00197	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00023	0.00194	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000229	0.00193	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000229	0.00193	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000229	0.00193	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000224	0.00189	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000221	0.00187	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000221	0.00187	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000217	0.00183	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000217	0.00183	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000217	0.00183	CbGpPWpGaD
Acetophenazine—DRD2—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000215	0.00181	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.00021	0.0235	CrCbGaD
Acetophenazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000207	0.0232	CrCbGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000206	0.00173	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.00171	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000201	0.0017	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0002	0.00168	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000199	0.00168	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000198	0.0222	CrCbGaD
Acetophenazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000198	0.0221	CrCbGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000197	0.00166	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000195	0.00165	CbGpPWpGaD
Acetophenazine—DRD1—brain—attention deficit hyperactivity disorder	0.000193	0.0783	CbGeAlD
Acetophenazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000192	0.0215	CrCbGaD
Acetophenazine—DRD2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000192	0.00162	CbGpPWpGaD
Acetophenazine—DRD2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00019	0.0016	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000187	0.00158	CbGpPWpGaD
Acetophenazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000187	0.0209	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000187	0.00157	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000186	0.00157	CbGpPWpGaD
Acetophenazine—Flupentixol—DRD2—attention deficit hyperactivity disorder	0.000186	0.0208	CrCbGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000181	0.00153	CbGpPWpGaD
Acetophenazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000181	0.0736	CbGeAlD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.0015	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000176	0.00148	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000174	0.00147	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000173	0.00145	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000169	0.00143	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000166	0.0014	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000162	0.00137	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00016	0.00135	CbGpPWpGaD
Acetophenazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.00016	0.0179	CrCbGaD
Acetophenazine—DRD1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000157	0.00132	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000155	0.00131	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.0013	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000153	0.00129	CbGpPWpGaD
Acetophenazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000152	0.00128	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000152	0.00128	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000151	0.00127	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00015	0.00127	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00015	0.00127	CbGpPWpGaD
Acetophenazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000149	0.0605	CbGeAlD
Acetophenazine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000148	0.0166	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000147	0.00124	CbGpPWpGaD
Acetophenazine—Flupentixol—HTR2A—attention deficit hyperactivity disorder	0.000144	0.0161	CrCbGaD
Acetophenazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000144	0.0161	CrCbGaD
Acetophenazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000143	0.0583	CbGeAlD
Acetophenazine—DRD1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000142	0.00119	CbGpPWpGaD
Acetophenazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.00014	0.0569	CbGeAlD
Acetophenazine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.00014	0.0156	CrCbGaD
Acetophenazine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.0154	CrCbGaD
Acetophenazine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.0153	CrCbGaD
Acetophenazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000133	0.0149	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000133	0.00112	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000131	0.00111	CbGpPWpGaD
Acetophenazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00013	0.0011	CbGpPWpGaD
Acetophenazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.00013	0.0145	CrCbGaD
Acetophenazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000129	0.0144	CrCbGaD
Acetophenazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000128	0.0143	CrCbGaD
Acetophenazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	0.000128	0.0143	CrCbGaD
Acetophenazine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.0142	CrCbGaD
Acetophenazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000126	0.0141	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000125	0.00105	CbGpPWpGaD
Acetophenazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000125	0.0139	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000123	0.00103	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000122	0.00103	CbGpPWpGaD
Acetophenazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.0133	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000118	0.000997	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000116	0.00098	CbGpPWpGaD
Acetophenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000115	0.000968	CbGpPWpGaD
Acetophenazine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000115	0.000968	CbGpPWpGaD
Acetophenazine—DRD2—brain—attention deficit hyperactivity disorder	0.000114	0.0463	CbGeAlD
Acetophenazine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000114	0.000958	CbGpPWpGaD
Acetophenazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000113	0.0126	CrCbGaD
Acetophenazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.000113	0.0126	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000113	0.000949	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000111	0.000938	CbGpPWpGaD
Acetophenazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.000111	0.0124	CrCbGaD
Acetophenazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000107	0.012	CrCbGaD
Acetophenazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000106	0.0119	CrCbGaD
Acetophenazine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	0.000105	0.0117	CrCbGaD
Acetophenazine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	0.000105	0.0117	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000103	0.000872	CbGpPWpGaD
Acetophenazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.0115	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000102	0.000861	CbGpPWpGaD
Acetophenazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000101	0.0113	CrCbGaD
Acetophenazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	0.000101	0.0113	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0001	0.000844	CbGpPWpGaD
Acetophenazine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	9.93e-05	0.000837	CbGpPWpGaD
Acetophenazine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	9.84e-05	0.00083	CbGpPWpGaD
Acetophenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.84e-05	0.00083	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	9.84e-05	0.000829	CbGpPWpGaD
Acetophenazine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	9.67e-05	0.0108	CrCbGaD
Acetophenazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	9.52e-05	0.0107	CrCbGaD
Acetophenazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	9.38e-05	0.0105	CrCbGaD
Acetophenazine—Promazine—DRD4—attention deficit hyperactivity disorder	9.31e-05	0.0104	CrCbGaD
Acetophenazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	9.26e-05	0.0104	CrCbGaD
Acetophenazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	9.16e-05	0.0103	CrCbGaD
Acetophenazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	9.09e-05	0.0102	CrCbGaD
Acetophenazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	9.02e-05	0.0101	CrCbGaD
Acetophenazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	9.02e-05	0.0101	CrCbGaD
Acetophenazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	8.99e-05	0.0101	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.93e-05	0.000753	CbGpPWpGaD
Acetophenazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	8.9e-05	0.00996	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.89e-05	0.000749	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.86e-05	0.000747	CbGpPWpGaD
Acetophenazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	8.85e-05	0.0099	CrCbGaD
Acetophenazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	8.74e-05	0.00978	CrCbGaD
Acetophenazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	8.73e-05	0.00977	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.71e-05	0.000734	CbGpPWpGaD
Acetophenazine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.71e-05	0.000734	CbGpPWpGaD
Acetophenazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	8.62e-05	0.00964	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	8.6e-05	0.000725	CbGpPWpGaD
Acetophenazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	8.57e-05	0.00959	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	8.54e-05	0.00072	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.5e-05	0.000716	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	8.45e-05	0.00945	CrCbGaD
Acetophenazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	8.19e-05	0.00917	CrCbGaD
Acetophenazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	8.12e-05	0.00909	CrCbGaD
Acetophenazine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	8.08e-05	0.00904	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	8.04e-05	0.000678	CbGpPWpGaD
Acetophenazine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	8.03e-05	0.00899	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	8.01e-05	0.000675	CbGpPWpGaD
Acetophenazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	7.96e-05	0.00891	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.91e-05	0.000666	CbGpPWpGaD
Acetophenazine—Promazine—DRD1—attention deficit hyperactivity disorder	7.88e-05	0.00881	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.81e-05	0.000659	CbGpPWpGaD
Acetophenazine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.81e-05	0.000658	CbGpPWpGaD
Acetophenazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	7.79e-05	0.00872	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.72e-05	0.00065	CbGpPWpGaD
Acetophenazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	7.5e-05	0.00839	CrCbGaD
Acetophenazine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.49e-05	0.000632	CbGpPWpGaD
Acetophenazine—Trazodone—HTR2A—attention deficit hyperactivity disorder	7.43e-05	0.00832	CrCbGaD
Acetophenazine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	7.43e-05	0.000626	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.43e-05	0.000626	CbGpPWpGaD
Acetophenazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	7.32e-05	0.00819	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	7.27e-05	0.000613	CbGpPWpGaD
Acetophenazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	7.25e-05	0.00811	CrCbGaD
Acetophenazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	7.08e-05	0.00792	CrCbGaD
Acetophenazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	7.06e-05	0.0079	CrCbGaD
Acetophenazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	6.97e-05	0.00779	CrCbGaD
Acetophenazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	6.97e-05	0.00779	CrCbGaD
Acetophenazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	6.93e-05	0.00776	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.9e-05	0.000582	CbGpPWpGaD
Acetophenazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	6.88e-05	0.00769	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.74e-05	0.000568	CbGpPWpGaD
Acetophenazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	6.71e-05	0.00751	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.71e-05	0.000566	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.69e-05	0.000564	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.58e-05	0.000554	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.57e-05	0.000554	CbGpPWpGaD
Acetophenazine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.49e-05	0.000547	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.45e-05	0.000544	CbGpPWpGaD
Acetophenazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	6.44e-05	0.00721	CrCbGaD
Acetophenazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	6.41e-05	0.00717	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.27e-05	0.000528	CbGpPWpGaD
Acetophenazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	6.23e-05	0.00697	CrCbGaD
Acetophenazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	6.16e-05	0.00689	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.07e-05	0.000512	CbGpPWpGaD
Acetophenazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	6.04e-05	0.00676	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	6.04e-05	0.000509	CbGpPWpGaD
Acetophenazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	6.02e-05	0.00674	CrCbGaD
Acetophenazine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.97e-05	0.000503	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.9e-05	0.000497	CbGpPWpGaD
Acetophenazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	5.79e-05	0.00648	CrCbGaD
Acetophenazine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.61e-05	0.000473	CbGpPWpGaD
Acetophenazine—Promazine—DRD2—attention deficit hyperactivity disorder	5.55e-05	0.00621	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	5.28e-05	0.000445	CbGpPWpGaD
Acetophenazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	5.19e-05	0.0058	CrCbGaD
Acetophenazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	5.09e-05	0.000429	CbGpPWpGaD
Acetophenazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	4.95e-05	0.00554	CrCbGaD
Acetophenazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	4.89e-05	0.00547	CrCbGaD
Acetophenazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	4.81e-05	0.00539	CrCbGaD
Acetophenazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	4.76e-05	0.00533	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.75e-05	0.0004	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.67e-05	0.000394	CbGpPWpGaD
Acetophenazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	4.67e-05	0.00522	CrCbGaD
Acetophenazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.61e-05	0.000389	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.56e-05	0.000384	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	4.3e-05	0.000362	CbGpPWpGaD
Acetophenazine—Promazine—HTR2A—attention deficit hyperactivity disorder	4.29e-05	0.0048	CrCbGaD
Acetophenazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.24e-05	0.000357	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.98e-05	0.000336	CbGpPWpGaD
Acetophenazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.85e-05	0.000324	CbGpPWpGaD
Acetophenazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	3.78e-05	0.00423	CrCbGaD
Acetophenazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.7e-05	0.000312	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.59e-05	0.000302	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.53e-05	0.000297	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.48e-05	0.000294	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.01e-05	0.000254	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000192	CbGpPWpGaD
Acetophenazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.59e-05	0.000134	CbGpPWpGaD
Acetophenazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.2e-05	0.000101	CbGpPWpGaD
